Sarah
A.
Abramowitz,
BA;
Kristin
Boulier,
MD;
Karl
Keat,
BS;
Katie
M.
Cardone,
Manu
Shivakumar,
John
DePaolo,
MD,
PhD;
Renae
Judy,
MS;
Francisca
Bermudez,
Nour
Mimouni,
Christopher
Neylan,
Dokyoon
Kim,
Daniel
J.
Rader,
Marylyn
D.
Ritchie,
Benjamin
F.
Voight,
Bogdan
Pasaniuc,
Michael
G.
Levin,
Scott
Damrauer,
Penn
Medicine
BioBank;
J
Rader;
D
Ritchie;
JoEllen
Weaver;
Nawar
Naseer;
Giorgio
Sirugo;
Afiya
Poindexter;
Yi-An
Ko;
Kyle
P.
Nerz;
Meghan
Livingstone;
Fred
Vadivieso;
Stephanie
DerOhannessian;
Teo
Tran;
Julia
Stephanowski;
Salma
Santos;
Ned
Haubein;
Joseph
Dunn;
Anurag
Verma;
Colleen
Kripke;
Marjorie
Risman;
Judy;
Colin
Wollack;
Shefali
S.
M
Damrauer;
Yuki
Bradford;
Dudek;
Theodore
Drivas
Nature Communications,
Год журнала:
2025,
Номер
16(1)
Опубликована: Фев. 12, 2025
Polygenic
risk
scores
(PRS)
continue
to
improve
with
novel
methods
and
expanding
genome-wide
association
studies.
Healthcare
commercial
laboratories
are
increasingly
deploying
PRS
reports
patients,
but
it
is
unknown
how
the
classification
of
high
polygenic
changes
across
individual
PRS.
Here,
we
assess
performance
cataloged
for
three
complex
traits.
We
chronologically
order
all
trait-related
publications
(Pubn)
identify
single
Best(Pubn)
each
Pubn
that
has
strongest
target
outcome.
While
demonstrates
generally
consistent
population-level
strengths
associations,
individuals
in
top
10%
distribution
varies
widely.
Using
PRSmix
framework,
which
integrates
information
several
prediction,
generate
corresponding
ChronoAdd(Pubn)
combine
from
up
including
Pubn.
When
compared
Best(Pubn),
demonstrate
more
high-risk
amongst
themselves.
This
integrative
scoring
approach
provides
stable
reliable
an
adaptable
framework
into
new
can
be
incorporated
as
they
introduced,
integrating
easily
current
implementation
strategies.
Variability
exists
classifying
diseases.
Here
authors
show
improves
consistency
overall
toward
clinical
applications.
JACC. Cardiovascular imaging,
Год журнала:
2025,
Номер
unknown
Опубликована: Март 1, 2025
The
2018
ACC
(American
College
of
Cardiology)/AHA
Heart
Association)
and
2021
ESC
(European
Society
Cardiology)/EAS
Atherosclerosis
Society)
guidelines
recommend
coronary
artery
calcium
(CAC)
score
for
risk
refinement
in
primary
prevention
atherosclerotic
cardiovascular
disease
(ASCVD).
study
sought
to
compare
CAC
utility
as
a
risk-refining
tool
following
the
ACC/AHA
guideline
using
pooled
cohort
equations
(PCE)
or
PREVENT
(Predicting
Risk
EVENTs)
ESC/EAS
SCORE2
(Systematic
COronary
Evaluation
2).
A
total
1,903
statin-naive
participants
55
75
years
age,
free
ASCVD
diabetes,
with
low-density
lipoprotein
cholesterol
<190
mg/dL
from
prospective
population-based
Rotterdam
Study
were
included.
Per
guidelines,
we
determined
proportions
scan-eligible
reclassified
men
women,
incidence
rates,
numbers
needed
treat
10
(NNT10y).
By
(PCE),
18.3%
11.9%
by
(PREVENT),
13.4%
3.4%
women
eligible
scan.
ESC/EAS,
46.6%
44.9%
eligible.
Proportions
uprisked
derisked
individuals
varied
per
guideline.
Among
CAC-eligible
individuals,
rates
ranged
9.3
23.8
1,000
person-years,
estimated
NNT10y
prevent
1
event,
based
on
high-intensity
statin
use,
11
26.
differ
selection
application
ASCVD.
Guideline-directed
middle-aged
apparently
healthy
population
improved
stratification
at
an
acceptable
both
guidelines.
JAMA,
Год журнала:
2024,
Номер
332(12), С. 961 - 961
Опубликована: Июль 29, 2024
This
Viewpoint
explores
decision
thresholds
and
the
evidence
that
informs
them
as
well
how
clinicians
may
respond
to
an
updated
risk
estimation
model,
such
Predicting
Risk
of
cardiovascular
disease
EVENTs
equations.
medRxiv (Cold Spring Harbor Laboratory),
Год журнала:
2025,
Номер
unknown
Опубликована: Янв. 29, 2025
ABSTRACT
Background
Primary
prevention
of
cardiovascular
disease
relies
on
accurate
risk
assessment
using
scores
such
as
the
Pooled
Cohort
Equations
(PCE)
and
PREVENT.
However,
necessary
input
variables
for
these
are
often
unavailable
in
electronic
health
record
(EHR),
information
from
routinely
collected
data
(e.g.,
non-contrast
chest
CT)
may
further
improve
performance.
Here,
we
test
whether
a
prediction
model
based
structural
features
heart
aorta
CT
has
added
value
to
existing
clinical
algorithms
predicting
major
adverse
events
(MACE).
Methods
We
developed
LASSO
predict
fatal
MACE
over
12
years
follow-up
radiomics
describing
cardiac
chamber
segmentations
13,437
lung
cancer
screening
CTs
National
Lung
Screening
Trial.
compared
this
PCE
PREVENT
an
external
testing
set
4,303
individuals
who
had
at
Mass
General
Brigham
site
no
history
diabetes,
prior
MACE,
or
statin
treatment.
Discrimination
incident
was
assessed
concordance
index.
used
binary
threshold
determine
rates
patients
were
statin-eligible
ineligible
by
PCE/PREVENT
(≥7.5%
risk)
score
(≥5.0%
risk).
Results
stratified
all
available
calculate
scores.
In
(n
=
4,303;
mean
age
61.5
±
9.3
years;
47.1%
male),
8.0%
median
5.1
follow-up.
The
significantly
improved
discrimination
beyond
(c-index
0.653
vs.
0.567,
p
<
0.001)
performed
similarly
missing
inputs.
Those
both
2.6-fold
higher
incidence
than
those
eligible
alone
(29.5
[20.5,
39.1]
11.2
[8.0,
14.4]
per
1,000
person-years
among
PCE-eligible
individuals).
inputs,
1.8-fold
statin-ineligible
[21.9,
37.6]
16.7
[14.3,
19.0]
1000
person-years).
Similar
results
found
when
comparing
score.
Left
ventricular
volume
short
axis
length
most
predictive
myocardial
infarction,
while
left
atrial
sphericity
surface-to-volume
ratio
stroke.
Conclusions
Based
single
CT,
shape-based
predicted
demonstrated
similar
performance
inputs
standard
calculators.
Patients
high-risk
benefit
intensified
primary
prescription).
Journal of the American Heart Association,
Год журнала:
2025,
Номер
unknown
Опубликована: Фев. 8, 2025
Background
We
compared
the
atherosclerotic
cardiovascular
disease
(ASCVD)
risk
prediction
performance
of
American
Heart
Association's
Predicting
Risk
Cardiovascular
Disease
Events
(PREVENT)
Base
and
PREVENT
Full
equations
(includes
urine
albumin/creatinine
ratio,
glycated
hemoglobin,
social
deprivation
index)
with
pooled
cohort
(PCEs).
Methods
included
adults,
aged
40
to
75
years,
no
history
ASCVD,
diabetes,
or
statin
use
in
2009
from
Kaiser
Permanente
Southern
California
followed
up
through
2019.
ASCVD
was
defined
as
myocardial
infarction,
fatal
coronary
heart
disease,
nonfatal
ischemic
stroke.
model
discrimination
(Harrell
C),
mean
calibration
(estimated
ratio
predicted/observed
event
rates),
curve
among
overall
population
stratified
by
sex
race
ethnicity.
Results
Of
559
241
adults
(mean
age,
54
years;
11%
Asian,
non‐Hispanic
Black,
32%
Hispanic),
10
695
developed
an
(median
follow‐up,
years).
Harrell
C
0.741
(95%
CI,
0.736–0.745)
for
Base,
0.743
0.738–0.748)
Full,
0.736–0.746)
PCEs.
Compared
PCEs,
both
improved
men
but
not
women,
Black
other
races
ethnicities.
Both
were
well
calibrated
calibration,
0.85–1.36;
slope,
0.69–1.27),
whereas
PCEs
overestimated
10‐year
1.80–2.18;
0.32–0.45).
Conclusions
better
predict
absolute
across
racial
ethnic
groups
a
contemporary
US
adult
population.
Review
The
Role
of
Risk
Equations
in
Primary
Prevention
Atherosclerotic
Cardiovascular
Disease
Rishi
Rikhi
and
Michael
D.
Shapiro
*
Center
for
Disease,
Section
on
Medicine,
Department
Internal
Wake
Forest
University
School
Winston-Salem,
NC
27157,
USA
Correspondence:
[email protected];
Tel.:
+1-(336)-713-7085;
Fax:
+1-(336)-716-9188
Received:
24
January
2025;
Accepted:
11
February
Published:
1
March
2025
Abstract:
cardiovascular
disease
(ASCVD)
is
the
leading
cause
death
United
States.
2018
American
Heart
Association
(AHA)/American
College
Cardiology
(ACC)
blood
cholesterol
guideline
recommends
use
pooled
cohort
equations
(PCE)
assessment
10-year
ASCVD
risk
participants
aged
40–75
years
without
a
history
or
diabetes,
low-density
lipoprotein-cholesterol
(LDL-C)
≥70
mg/dL
<190
mg/dL.
Recently,
AHA
released
Predicting
(CVD)
EVENTs
(PREVENT)
that
calculate
both
10-
30-year
ASCVD,
CVD,
heart
failure
(HF)
30–79
years.
This
review
provides
an
overview
primary
prevention
performance
PREVENT
compared
to
PCE.
offers
enhanced
approach
by
integrating
markers
cardiovascular,
kidney,
metabolic
health
along
with
social
determinants
health,
providing
superior
calibration
discrimination
holds
promise
refining
statin
eligibility
identifying
individuals
at
ASCVD.
However,
additional
research
essential
define
clinical
thresholds
evaluate
its
potential
directing
emerging
preventive
therapies.
This
cross-sectional
study
uses
National
Health
and
Nutrition
Examination
Survey
data
to
examine
the
number
of
US
adults
eligible
for
semaglutide
across
all
current
indications.